Refeeding Syndrome Among Older Adults
RFS
Safe Refeeding of Severely Malnourished Patients 65 Years or Older
1 other identifier
interventional
84
1 country
1
Brief Summary
Malnutrition is highly prevalent among older adults. Adequate treatment is crucial to maintain health, improve functional status and independency. For severely malnourished patient, tube feeding is often the most effective treatment, but it also implies a risk of developing refeeding syndrome (RFS). RFS is described as fluid and electrolyte shifts particular hypophosphatemia when recommencing nutrition, potentially causing fatal complications. In 2006 National Institute for Health and Care Excellence (NICE) developed guidelines regarding 1) detecting patients at risk for RFS and 2) a treatment plan for refeeding severely malnourished patients. These guidelines have never been validated. Hence, there is a need to explore the use of different refeeding regimens in the treatment of older malnourished patients, in regards to assess safety, as well as the impact of the treatment, on functional status, independency, quality of life and RFS. This will be the first randomized controlled trial (RCT) that challenges the existing NICE guidelines. A blinded RCT study, with the aim of tube feeding patients at risk for developing RFS, and assigned either to an intervention group or to a control group, comparing the different refeeding regimens. This study will help develop safe and validated refeeding protocols for severely malnourished older patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 17, 2017
CompletedStudy Start
First participant enrolled
April 10, 2017
CompletedFirst Posted
Study publicly available on registry
May 5, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 6, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 8, 2019
CompletedSeptember 27, 2021
September 1, 2021
2.3 years
February 17, 2017
September 21, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Hand grip strength
Using Jamar Pluss Digital +, Measuring change in kg from baseline, day 4, 7 and at 3months.
Baseline and at three months.
Secondary Outcomes (8)
EQ-5D-5L
Day 4 and after 3 months
Alertness, attention, acute change, and abbreviated mental test (The 4AT),
Day 4 and after 3 months
Mortality
register mortality after 3 months and 1-year
Readmission rates
Readmissionrates after 30 days
Weight measurement
Day 1, day 4 and on day 7 after staring with tubefeeding in hospital, and at 3 months
- +3 more secondary outcomes
Study Arms (2)
NICE guidelines for refeeding syndrome
EXPERIMENTALHigh protein enteral tubefeeding solution. NICE guidelines regarding refeeding syndrome, based on a very cautious refeeding regime reaching estimated calorie and protein needs within 7 days, compared to a protocol at Diakonhjemmet Hospital using a higher starting rate, reaching estimated needs within 3 days.
Diakonhjemmet Hospital Protocol(DS)
EXPERIMENTALHigh protein enteral tubefeeding solution. The intervention group, Diakonhjemmets feeding protocol, will start at 20 calories a kg a day, and increasing until estimated needs are met within 3days
Interventions
NICE guidelines regarding refeeding syndrome, based on a very cautious refeeding regime reaching estimated calorie and protein needs within 7 days, compared to a protocol at Diakonhjemmet Hospital using a higher starting rate, reaching estimated needs within 3 days.
Eligibility Criteria
You may qualify if:
- Malnourished: According to NICE screening tool:
- BMI \<16kg/m2, or weight loss, or little nutritional intake, Or: BMI\< 18.5kg/m2, and; weight loss, or little nutritional intake, or alcohol, drug abuse, chemotherapy, antacids diuretics.
You may not qualify if:
- Severe dementia (palliative stage).
- Already on artificial nutrition
- Terminal stage of life, defined as receiving only palliative medical treatment
- Readmissions (patients will not be included twice)
- Intensive care patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Diakonhjemmet Hospitallead
- Norwegian Health Associationcollaborator
Study Sites (1)
Diakonhjemmet Hospital
Oslo, Postboks 23 Vinderen, 0319, Norway
Related Publications (1)
Olsen SU, Tazmini K, Aas AM, Ranhoff AH, Pripp AH, Hesseberg K, Sunde S, Bye A. The incidence and mortality of refeeding syndrome in older hospitalized patients, based on three different diagnostic criteria: A longitudinal study. Clin Nutr ESPEN. 2024 Jun;61:101-107. doi: 10.1016/j.clnesp.2024.03.006. Epub 2024 Mar 15.
PMID: 38777421DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Anette H Ranhoff, Professor
Diakonhjemmet Hospital, Vinderen, Postboks 23, 0319 Oslo, Norway
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Patients and care provider(nurse) will be masked(not informed), Patients will be screened (height and weight) and handgrip strength will be performed by the investigator. Patients will sign a written consent, and then randomized to either the control or an intervention group. Patients will be tested on day 4, 7 and at 3 months by a research assistant/outcome assessor and is blinded treatment allocations. Blood tests are drawn daily. A nurse will administered the tubefeeding according to written orders in the medical journal; nurses are not informed about treatment allocation or the outcome measures. Physicians are informed about the study, but will not know what treatment patients will receive.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Dietitian
Study Record Dates
First Submitted
February 17, 2017
First Posted
May 5, 2017
Study Start
April 10, 2017
Primary Completion
August 6, 2019
Study Completion
October 8, 2019
Last Updated
September 27, 2021
Record last verified: 2021-09